Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: O97001
Term | Name | Level | Count |
---|---|---|---|
GO:0001680 | tRNA 3'-terminal CCA addition | 9 | 11 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006399 | tRNA metabolic process | 7 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008033 | tRNA processing | 8 | 11 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0031123 | RNA 3'-end processing | 7 | 12 |
GO:0034470 | ncRNA processing | 7 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 11 |
GO:0042780 | tRNA 3'-end processing | 8 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071076 | RNA 3' uridylation | 8 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0003824 | catalytic activity | 1 | 13 |
GO:0004652 | obsolete polynucleotide adenylyltransferase activity | 6 | 4 |
GO:0004810 | CCA tRNA nucleotidyltransferase activity | 8 | 4 |
GO:0005488 | binding | 1 | 12 |
GO:0016740 | transferase activity | 2 | 13 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 |
GO:0016779 | nucleotidyltransferase activity | 4 | 12 |
GO:0050265 | RNA uridylyltransferase activity | 4 | 12 |
GO:0052929 | ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity | 9 | 4 |
GO:0070566 | adenylyltransferase activity | 5 | 4 |
GO:0070569 | uridylyltransferase activity | 5 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 4 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:1990817 | poly(A) RNA polymerase activity | 7 | 4 |
GO:0052927 | CTP:tRNA cytidylyltransferase activity | 5 | 2 |
GO:0070567 | cytidylyltransferase activity | 5 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 146 | 148 | PF00675 | 0.256 |
CLV_NRD_NRD_1 | 374 | 376 | PF00675 | 0.350 |
CLV_NRD_NRD_1 | 403 | 405 | PF00675 | 0.479 |
CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.256 |
CLV_PCSK_KEX2_1 | 301 | 303 | PF00082 | 0.514 |
CLV_PCSK_KEX2_1 | 374 | 376 | PF00082 | 0.358 |
CLV_PCSK_PC1ET2_1 | 301 | 303 | PF00082 | 0.514 |
CLV_PCSK_SKI1_1 | 147 | 151 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 345 | 349 | PF00082 | 0.543 |
CLV_PCSK_SKI1_1 | 404 | 408 | PF00082 | 0.425 |
CLV_PCSK_SKI1_1 | 416 | 420 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.276 |
CLV_PCSK_SKI1_1 | 501 | 505 | PF00082 | 0.459 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.330 |
DEG_APCC_DBOX_1 | 419 | 427 | PF00400 | 0.440 |
DEG_APCC_DBOX_1 | 43 | 51 | PF00400 | 0.480 |
DEG_MDM2_SWIB_1 | 452 | 459 | PF02201 | 0.491 |
DOC_MAPK_gen_1 | 301 | 309 | PF00069 | 0.490 |
DOC_MAPK_gen_1 | 31 | 38 | PF00069 | 0.396 |
DOC_MAPK_gen_1 | 404 | 412 | PF00069 | 0.485 |
DOC_MAPK_gen_1 | 497 | 504 | PF00069 | 0.477 |
DOC_MAPK_MEF2A_6 | 110 | 118 | PF00069 | 0.538 |
DOC_MAPK_MEF2A_6 | 331 | 338 | PF00069 | 0.469 |
DOC_MAPK_MEF2A_6 | 420 | 429 | PF00069 | 0.406 |
DOC_MAPK_MEF2A_6 | 497 | 504 | PF00069 | 0.479 |
DOC_MAPK_NFAT4_5 | 497 | 505 | PF00069 | 0.467 |
DOC_MAPK_RevD_3 | 266 | 280 | PF00069 | 0.554 |
DOC_PP1_RVXF_1 | 195 | 202 | PF00149 | 0.311 |
DOC_PP2B_LxvP_1 | 339 | 342 | PF13499 | 0.320 |
DOC_PP2B_LxvP_1 | 363 | 366 | PF13499 | 0.380 |
DOC_PP2B_LxvP_1 | 471 | 474 | PF13499 | 0.502 |
DOC_USP7_MATH_1 | 15 | 19 | PF00917 | 0.478 |
DOC_USP7_MATH_1 | 297 | 301 | PF00917 | 0.544 |
DOC_USP7_MATH_1 | 366 | 370 | PF00917 | 0.383 |
DOC_USP7_UBL2_3 | 239 | 243 | PF12436 | 0.507 |
DOC_USP7_UBL2_3 | 478 | 482 | PF12436 | 0.494 |
DOC_USP7_UBL2_3 | 497 | 501 | PF12436 | 0.439 |
DOC_WW_Pin1_4 | 506 | 511 | PF00397 | 0.526 |
LIG_14-3-3_CanoR_1 | 185 | 189 | PF00244 | 0.475 |
LIG_14-3-3_CanoR_1 | 308 | 315 | PF00244 | 0.436 |
LIG_14-3-3_CanoR_1 | 76 | 82 | PF00244 | 0.497 |
LIG_14-3-3_CanoR_1 | 87 | 92 | PF00244 | 0.456 |
LIG_Actin_WH2_2 | 17 | 35 | PF00022 | 0.473 |
LIG_Actin_WH2_2 | 488 | 503 | PF00022 | 0.515 |
LIG_APCC_ABBA_1 | 293 | 298 | PF00400 | 0.519 |
LIG_FHA_1 | 104 | 110 | PF00498 | 0.494 |
LIG_FHA_1 | 158 | 164 | PF00498 | 0.456 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.455 |
LIG_FHA_1 | 215 | 221 | PF00498 | 0.402 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.327 |
LIG_FHA_1 | 346 | 352 | PF00498 | 0.495 |
LIG_FHA_1 | 491 | 497 | PF00498 | 0.452 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.443 |
LIG_FHA_2 | 166 | 172 | PF00498 | 0.466 |
LIG_FHA_2 | 185 | 191 | PF00498 | 0.243 |
LIG_FHA_2 | 507 | 513 | PF00498 | 0.510 |
LIG_LIR_Gen_1 | 18 | 28 | PF02991 | 0.428 |
LIG_LIR_Gen_1 | 240 | 248 | PF02991 | 0.496 |
LIG_LIR_Gen_1 | 378 | 388 | PF02991 | 0.403 |
LIG_LIR_Gen_1 | 453 | 464 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 18 | 23 | PF02991 | 0.425 |
LIG_LIR_Nem_3 | 378 | 383 | PF02991 | 0.380 |
LIG_LIR_Nem_3 | 453 | 459 | PF02991 | 0.416 |
LIG_OCRL_FandH_1 | 154 | 166 | PF00620 | 0.514 |
LIG_Pex14_2 | 452 | 456 | PF04695 | 0.493 |
LIG_REV1ctd_RIR_1 | 341 | 349 | PF16727 | 0.503 |
LIG_SH2_CRK | 484 | 488 | PF00017 | 0.568 |
LIG_SH2_GRB2like | 126 | 129 | PF00017 | 0.470 |
LIG_SH2_STAT5 | 126 | 129 | PF00017 | 0.456 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.491 |
LIG_SH3_3 | 134 | 140 | PF00018 | 0.449 |
LIG_SH3_3 | 178 | 184 | PF00018 | 0.489 |
LIG_SH3_3 | 309 | 315 | PF00018 | 0.467 |
LIG_SH3_3 | 500 | 506 | PF00018 | 0.471 |
LIG_SUMO_SIM_anti_2 | 90 | 95 | PF11976 | 0.439 |
LIG_SUMO_SIM_par_1 | 265 | 270 | PF11976 | 0.495 |
LIG_SUMO_SIM_par_1 | 461 | 467 | PF11976 | 0.470 |
LIG_TYR_ITIM | 428 | 433 | PF00017 | 0.441 |
LIG_UBA3_1 | 224 | 231 | PF00899 | 0.398 |
LIG_UBA3_1 | 495 | 501 | PF00899 | 0.479 |
MOD_CK1_1 | 215 | 221 | PF00069 | 0.427 |
MOD_CK1_1 | 450 | 456 | PF00069 | 0.463 |
MOD_CK2_1 | 165 | 171 | PF00069 | 0.480 |
MOD_CK2_1 | 208 | 214 | PF00069 | 0.456 |
MOD_Cter_Amidation | 277 | 280 | PF01082 | 0.601 |
MOD_GlcNHglycan | 309 | 312 | PF01048 | 0.436 |
MOD_GlcNHglycan | 434 | 438 | PF01048 | 0.467 |
MOD_GlcNHglycan | 440 | 443 | PF01048 | 0.471 |
MOD_GlcNHglycan | 451 | 455 | PF01048 | 0.468 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.475 |
MOD_GSK3_1 | 208 | 215 | PF00069 | 0.404 |
MOD_GSK3_1 | 446 | 453 | PF00069 | 0.466 |
MOD_N-GLC_1 | 127 | 132 | PF02516 | 0.270 |
MOD_N-GLC_1 | 208 | 213 | PF02516 | 0.421 |
MOD_N-GLC_2 | 357 | 359 | PF02516 | 0.462 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.337 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.479 |
MOD_NEK2_1 | 267 | 272 | PF00069 | 0.403 |
MOD_NEK2_1 | 307 | 312 | PF00069 | 0.402 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.457 |
MOD_NEK2_2 | 15 | 20 | PF00069 | 0.420 |
MOD_NEK2_2 | 394 | 399 | PF00069 | 0.522 |
MOD_PKA_2 | 184 | 190 | PF00069 | 0.404 |
MOD_PKA_2 | 307 | 313 | PF00069 | 0.498 |
MOD_PKA_2 | 75 | 81 | PF00069 | 0.497 |
MOD_Plk_1 | 127 | 133 | PF00069 | 0.534 |
MOD_Plk_1 | 147 | 153 | PF00069 | 0.456 |
MOD_Plk_1 | 208 | 214 | PF00069 | 0.371 |
MOD_Plk_1 | 220 | 226 | PF00069 | 0.344 |
MOD_Plk_1 | 351 | 357 | PF00069 | 0.516 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.479 |
MOD_Plk_4 | 184 | 190 | PF00069 | 0.421 |
MOD_Plk_4 | 220 | 226 | PF00069 | 0.385 |
MOD_Plk_4 | 267 | 273 | PF00069 | 0.428 |
MOD_Plk_4 | 302 | 308 | PF00069 | 0.463 |
MOD_Plk_4 | 491 | 497 | PF00069 | 0.499 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.466 |
MOD_ProDKin_1 | 506 | 512 | PF00069 | 0.525 |
MOD_SUMO_rev_2 | 25 | 32 | PF00179 | 0.491 |
TRG_DiLeu_BaEn_1 | 435 | 440 | PF01217 | 0.372 |
TRG_DiLeu_BaEn_1 | 461 | 466 | PF01217 | 0.499 |
TRG_DiLeu_BaLyEn_6 | 191 | 196 | PF01217 | 0.368 |
TRG_DiLeu_BaLyEn_6 | 372 | 377 | PF01217 | 0.467 |
TRG_ENDOCYTIC_2 | 380 | 383 | PF00928 | 0.387 |
TRG_ENDOCYTIC_2 | 430 | 433 | PF00928 | 0.364 |
TRG_ER_diArg_1 | 173 | 176 | PF00400 | 0.519 |
TRG_ER_diArg_1 | 373 | 375 | PF00400 | 0.376 |
TRG_NES_CRM1_1 | 285 | 298 | PF08389 | 0.464 |
TRG_Pf-PMV_PEXEL_1 | 374 | 378 | PF00026 | 0.478 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HUG7 | Leptomonas seymouri | 68% | 99% |
A0A0S4JS32 | Bodo saltans | 33% | 100% |
A0A0S4JSB5 | Bodo saltans | 46% | 100% |
A0A1X0NL45 | Trypanosomatidae | 47% | 99% |
A0A3S7WNX9 | Leishmania donovani | 96% | 100% |
A0A422NNU3 | Trypanosoma rangeli | 47% | 100% |
A4H434 | Leishmania braziliensis | 82% | 100% |
A4HSB8 | Leishmania infantum | 97% | 100% |
A5UCK0 | Haemophilus influenzae (strain PittEE) | 24% | 100% |
A5UJ23 | Haemophilus influenzae (strain PittGG) | 24% | 100% |
C1DAG2 | Laribacter hongkongensis (strain HLHK9) | 27% | 100% |
C9ZYB2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 99% |
E9AKA0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
P45269 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 24% | 100% |
V5BI79 | Trypanosoma cruzi | 46% | 99% |